The effect of PPARγ agonist on SGLT2 and glucagon expressions in alpha cells under hyperglycemia

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Journal of Endocrinological Investigation

• Publication date

  2017-04-08

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1007/s40618-017-0659-1PMID 28391584
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Revitalization of pioglitazone: the optimum agent to be combined with a sodium‐glucose co‐transporter‐2 inhibitor

  2016cited by this paper
• Inhibition of the glucose transporter SGLT2 with dapagliflozin in pancreatic alpha cells triggers glucagon secretion

  2015cited by this paper
• Euglycemic Diabetic Ketoacidosis: A Predictable, Detectable, and Preventable Safety Concern With SGLT2 Inhibitors

  2015cited by this paper
• Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes.

  2015cited by this paper
• Dapagliflozin improves muscle insulin sensitivity but enhances endogenous glucose production.

  2014cited by this paper
• Metabolic response to sodium-glucose cotransporter 2 inhibition in type 2 diabetic patients.

  2014cited by this paper
• Tolbutamide Controls Glucagon Release From Mouse Islets Differently Than Glucose

  2013cited by this paper
• PPARγ signaling and metabolism: the good, the bad and the future

  2013cited by this paper
• Glucotoxicity and α Cell Dysfunction: Involvement of the PI3K/Akt Pathway in Glucose-Induced Insulin Resistance in Rat Islets and Clonal αTC1-6 Cells

  2012cited by this paper
• Glucagonocentric restructuring of diabetes: a pathophysiologic and therapeutic makeover.

  2012cited by this paper
• Dynamics of insulin secretion and the clinical implications for obesity and diabetes.

  2011cited by this paper
• Troglitazone ameliorates high glucose-induced EMT and dysfunction of SGLTs through PI3K/Akt, GSK-3β, Snail1, and β-catenin in renal proximal tubule cells.

  2010cited by this paper
• Glucagon-like peptide-1, but not glucose-dependent insulinotropic peptide, inhibits glucagon secretion via somatostatin (receptor subtype 2) in the perfused rat pancreas

  2008cited by this paper
• Alpha-cells of the endocrine pancreas: 35 years of research but the enigma remains.

  2007cited by this paper
• α-Cells of the Endocrine Pancreas: 35 Years of Research but the Enigma Remains.

  2007cited by this paper
• Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial.

  2005cited by this paper
• Islet β-cell secretion determines glucagon release from neighbouring α-cells

  2003cited by this paper
• Islet beta-cell secretion determines glucagon release from neighbouring alpha-cells.

  2003cited by this paper
• Pancreatic response to mild non-insulin-induced hypoglycemia does not involve extrinsic neural input.

  2001cited by this paper
• ATP-sensitive K+ channels in the hypothalamus are essential for the maintenance of glucose homeostasis

  2001cited by this paper
• Identification and functional characterization of the peroxisomal proliferator response element in rat GLUT2 promoter.

  2000cited by this paper
• High glucose inhibits glucose uptake in renal proximal tubule cells by oxidative stress and protein kinase C.

  2000cited by this paper
• Glucose-inhibition of glucagon secretion involves activation of GABAA-receptor chloride channels

  1989cited by this paper
• Relationship of glucagon suppression by insulin and somatostatin to the ambient glucose concentration.

  1987cited by this paper
• Regulation of glucagon release: Effects of insulin on the pancreatic A2-cell of the guinea pig

  1979cited by this paper
• Regulation of glucagon release: effects of insulin on the pancreatic A2-cell of the guinea pig.

  1979cited by this paper

• Hyaluronan induces ERK activation with minimal transcriptomic changes in pancreatic α-cells

  2026cites this paper
• Integrating network pharmacology, molecular docking, and molecular dynamics to explore the antidiabetic mechanism of Physalis angulata L.

  2025cites this paper
• PPARγ and Its Agonists in Chronic Kidney Disease

  2020influential citation
• Glucose transporters in pancreatic islets

  2020cites this paper
• Glucagon Receptor Signaling and Glucagon Resistance

  2019cites this paper